FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1458911000001103: Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24564301000001115 Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37922401000001112 Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet 2 x 12 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Is a Ibuprofen 200mg tablets 24 tablet true Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Is pack of Migrafen 200mg tablets (Chatfield Laboratories) false Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Has active ingredient Ibuprofen false Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Has excipient Beeswax false Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Has AMP Migrafen 200mg tablets (Chatfield Laboratories) true Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Has specific active ingredient Ibuprofen true Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Migrafen 200mg tablets (Chatfield Laboratories) 24 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start